Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
Charles River Labs (CRL) Stock Price & Analysis
468 Followers
CRL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$161.65 - $275.00
Previous Close$226.78
Volume544.69K
Average Volume (3M)529.29K
Market Cap
$11.65B
Enterprise Value$14.50B
Total Cash (Recent Filing)$276.77M
Total Debt (Recent Filing)$3.07B
Price to Earnings (P/E)24.6
Beta1.46
Next Earnings
May 09, 2024EPS Estimate
$2.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.21
Shares Outstanding51,349,770
10 Day Avg. Volume438,313
30 Day Avg. Volume529,292
Standard Deviation0.10
R-Squared0.53
Alpha-0.00084
Financial Highlights & Ratios
Price to Book (P/B)-32.15
Price to Sales (P/S)11.49
Price to Cash Flow (P/CF)13.20
P/FCF Ratio16.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.84
Enterprise Value/Gross Profit7.91
Enterprise Value/Ebitda16.91
Forecast
1Y Price Target
$275.22Price Target Upside18.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Charles River Labs News
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst raises price objective to $270, based on an expanded peer multiple and reiterates a Buy rating due to CRL’s strong competitive position and diversified portfolio.
Financial Performance4Q revenue modestly above expectations, indicating resilience in the company's financial performance.
Manufacturing PerformanceManufacturing segment showed better-than-anticipated performance, contributing to the overall positive results.
Bears Say
Financial PerformanceAdjusted Operating Profit Margin decreased mainly due to higher unallocated corporate costs, impacting profitability.
Revenue DeclineDiscovery Services revenue declined, putting pressure on the segment's profitability.
Uncertain RecoveryThe recovery timeline for Discovery & Safety Assessment remains uncertain, with cancellations elevated and bookings down.
---
Ownership Overview
2.73% Insiders
34.51% Mutual Funds
25.71% Other Institutional Investors
37.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRL FAQ
What was Charles River Laboratories Intl’s price range in the past 12 months?
Charles River Laboratories Intl lowest stock price was $161.65 and its highest was $275.00 in the past 12 months.
What is Charles River Laboratories Intl’s market cap?
Currently, no data Available
When is Charles River Laboratories Intl’s upcoming earnings report date?
Charles River Laboratories Intl’s upcoming earnings report date is May 09, 2024 which is in 16 days.
How were Charles River Laboratories Intl’s earnings last quarter?
Charles River Laboratories Intl released its earnings results on Feb 14, 2024. The company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.402 by $0.058.
Is Charles River Laboratories Intl overvalued?
According to Wall Street analysts Charles River Laboratories Intl’s price is currently Undervalued.
Does Charles River Laboratories Intl pay dividends?
Charles River Laboratories Intl does not currently pay dividends.
What is Charles River Laboratories Intl’s EPS estimate?
Charles River Laboratories Intl’s EPS estimate is $2.06.
How many shares outstanding does Charles River Laboratories Intl have?
Charles River Laboratories Intl has 51,349,770 shares outstanding.
What happened to Charles River Laboratories Intl’s price movement after its last earnings report?
Charles River Laboratories Intl reported an EPS of $2.46 in its last earnings report, beating expectations of $2.402. Following the earnings report the stock price went up 11.297%.
Which hedge fund is a major shareholder of Charles River Laboratories Intl?
Among the largest hedge funds holding Charles River Laboratories Intl’s share is Ariel Investments LLC. It holds Charles River Laboratories Intl’s shares valued at 248M.
---
Charles River Labs Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$275.22 (18.34% Upside)
$275.22 (18.34% Upside)
Blogger Sentiment
Bullish
CRL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 165.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.75%
12-Months-Change
Fundamentals
Return on Equity
14.44%
Trailing 12-Months
Asset Growth
7.79%
Trailing 12-Months
Company Description
Charles River Laboratories Intl
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
---
CRL Company Deck
---
CRL Earnings Call
Q4 2024
0:00 / 0:00
---
CRL Revenue Breakdown
63.34% DSA
19.19% RMS
17.47% Manufacturing
---
CRL Stock 12 Months Forecast
Average Price Target
$275.22
▲(18.34% Upside)
Technical Analysis
Best Analysts Covering CRL
1 Year
1 Year Success Rate
22/42 ratings generated profit
1 Year Average Return
+6.48%
reiterated a buy rating 20 days ago
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 52.38% of your transactions generating a profit, with an average return of +6.48% per trade.
---